Department of Neuropharmacology, The Scripps Research Institute, La
Jolla, California
 |
Introduction |
The
nucleus accumbens (NAcc), an interface region between limbic structures
(hippocampus, amygdala, and prefrontal cortex) and the extrapyramidal
motor system, modulates cognitive and motivational aspects of behavior
that are translated into motor activity (Dunah et al., 1996
).
Projecting GABAergic neurons, also containing mostly either substance
P or enkephalin, account for 90% of the neuronal population of
NAcc (Meredith, 1999
). These neurons receive massive dopaminergic input
from the ventral tegmental area, glutamatergic input from cortical and
subcortical regions, and GABA innervation from interneurons. The
physiology of the receptors for these transmitters is relatively well
known, because they have been heavily studied with regard to addiction
to psychostimulants, opiates, and alcohol (Koob et al., 1998
).
NAcc-projecting neurons also receive inputs from acetylcholine- and
somatostatin-containing interneurons (Groenewegen et al., 1991
;
Meredith, 1999
), but relatively little is known about the physiology of
receptors for these ligands in NAcc. Furthermore, some data suggest
that other receptors, including glycine receptors, remain to be
identified and characterized.
Glycine receptors, along with GABA receptors, represent the primary
fast inhibitory mechanisms in the central nervous system. Activation of
glycine receptors opens anionic channels that hyperpolarize neurons.
Until recently, it was generally believed that glycine receptors were
almost exclusively found in the spinal cord and brainstem of adult rats
(Rajendra et al., 1997
). However, recent findings suggest that these
receptors may also be expressed in upper brainstem regions (Rampon et
al., 1996
). Recent studies also reported the presence of glycine
receptors in forebrain structures (Yoon et al., 1998
; Mori et al.,
2002
).
Glycine receptors are heteromultimeric receptors. Molecular approaches
have revealed a certain diversity of glycine receptor subunits. To
date, four different
and one
subunit have been identified
(Legendre, 2001
). Examination of the organization of glycine receptors
revealed that glycine receptors are pentameric with an invariant
stoichiometry of three
and two
subunits (Langosch et al.,
1988
). Although the expression of the
subunit matches that of
subunits in spinal cord, pons, and midbrain, there is evidence that
mRNA expression does not fully match that of
subunits in the brain
(Fujita et al., 1991
; Malosio et al., 1991
). Thus, it was established
that forebrain regions such as nucleus accumbens and striatum express
subunits, although in moderate levels (Fujita et al., 1991
; Kirsch
and Betz, 1993
; Kirsch et al., 1993
), but lack the
subunit (Sato et
al., 1991
; Malosio et al., 1991
) that carries the binding site for
glycine (Pfeiffer et al., 1982
).
This absence of a systematic overlap between
and
subunit
expression has prompted some investigators to suggest that additional
subunits, which could confer different properties for glycine receptors, remain to be discovered (Betz et al., 1999
). It was also
suggested that
subunits may form part of another receptor complex.
Herein, we demonstrate for the first time in a subpopulation of NAcc
neurons the existence of a functional receptor with
electrophysiological properties reminiscent of glycine receptors but
with a distinctive pharmacological profile.
 |
Materials and Methods |
Animals, Slice Preparation, and Experimental Solutions.
We
used male Sprague-Dawley rats (100-200 g) to prepare NAcc slices. The
rats were anesthetized with 4% halothane, decapitated, and the brains
rapidly transferred into a cold (4°C) oxygenated, low-calcium
HEPES-buffered salt solution: 234 mM sucrose, 2.5 mM KCl, 2 mM
NaH2PO4, 11 mM glucose, 4 mM MgSO4, 2 mM CaCl2, and 1.5 mM HEPES. We glued a tissue block containing NAcc to a Teflon chuck
and cut it transversally with a Vibroslicer (Campden Instruments, Loughborough, UK). Then we incubated the slices (400 µm in thickness) for up to 6 h at room temperature (20-22°C) in a gassed (95%
O2 and 5% CO2)
NaHCO3-buffered saline solution: 116.4 mM NaCl,
1.8 mM CaCl2, 0.4 mM MgSO4,
5.36 mM KCl, 0.89 mM
NaH2PO4, 5.5 mM glucose, 24 mM NaHCO3, 100 mM glutathione, 1 mM
nitro-arginine, and 1 mM kynurenic acid. pH was adjusted to 7.35 with
NaOH (osmolarity 300-305 mOsM/l). After 1 h of incubation, we
dissected out the region of the nucleus accumbens with the aid of a
dissecting microscope. We incubated the tissue for 25 min in an
oxygenated (100% O2 and constant stirring)
HEPES-buffered solution in the inner chamber of a Cell-Stirr flask
(Wheaton, Millville, NJ) that contained papain (1 mg/ml) and 136 mM
NaCl, 0.44 mM KH2PO4, 2.2 mM KCl, 0.35 mM NaH2PO4,
5.5 mM glucose, 10 mM HEPES, 100 mM glutathione, 1 mM nitro-arginine, 1 mM kynurenic acid, and 1 mM pyruvic acid (pH 7.35 with NaOH, osmolarity
300-305 mOsM). The temperature of this solution was kept constant
(36°C) by a circulating water bath in the outer chamber of the flask
(Stefani et al., 1994
; Martin et al., 2002
).
After enzymatic digestion, we transferred the tissue into a centrifuge
tube and rinsed it three to four times with the
Na+-isethionate solution. We then filled the tube
with 5 ml of Na+-isethionate solution and after
10 min, triturated the tissue using fire-polished Pasteur pipettes with
successively smaller tip diameters. We plated the supernatant onto a
35-mm Petri dish placed on the stage of the inverted microscope. The
cells were allowed to attach to the dish for 10 min before replacing
the Na+-isethionate solution with normal external
solution at a rate of 1.5 ml/min. This solution was composed of 142 mM
NaCl, 2 mM KCl, 1 mM CaCl2, 23 mM glucose, 15 mM
HEPES, and 10 mM glucose (pH 7.35 with NaOH, osmolarity 300 mOsM/l).
The chloride-free solution was prepared by replacing NaCl with
Na+-isethionate. Na+-free
solution was prepared by substituting NaCl with
N-methyl-D-glucamide; chloride was
provided by HCl when the pH was readjusted. For study of the effects of
Ba2+, we replaced CaCl2
with BaCl2.
Whole-Cell Recordings.
We used standard whole-cell recording
methods (Hamill et al., 1981
). Briefly, we pulled patch electrodes from
borosilicate capillary glass (Sutter Instruments, Novato, CA) on a
Flaming-Brown puller (Sutter Instruments) to a final resistance of 1.8 to 2.2 M
. We filled the electrodes with a solution that consisted of 120 mM CsF, 10 mM CsCl, 11 mM EGTA, 10 mM HEPES, and 0.5 mM
CaCl2 (pH 7.35 with CsOH; osmolarity 270-275
mOsM). The capillaries were first filled through the tip and then
backfilled with the recording solution. We recorded in voltage-clamp
mode with an Axopatch 1D amplifier and a DAC Digidata 1200 interface
from Axon Instruments (Union City, CA). The signal was filtered at 5 kHz and digitized at 1 kHz. The series resistance was compensated (70-80%) only when the ramp protocol was used. We subtracted the NMDA
current obtained with the ramp from the membrane response recorded in
absence of NMDA and glycine. Potentials were not corrected for the
liquid junction potential but are estimated to be +4 mV.
Superfusion and Drug Application.
Control and
drug-containing solutions were applied by gravity at a rate of 1.5 ml/s, using a rapid three-barrel capillary superfusion device (Warner
Instrument, Hamden, CT) with the pipette tips placed about 200 µm
from the recorded cell. The flow of solutions was controlled by
solenoid valves. Each capillary had a tip diameter of 500 µm, and the
distance from center to center was 700 µm. The barrel was attached to
a motor, allowing fast lateral motions controlled by pClamp 6 (Axon
Instruments), our data acquisition program. A drug onset time of 20 ms
for the application system was determined by measuring the changes in
the tip potential of the recording pipette filled with intracellular
solution as the perfusion was switched from a normal to a 1:2 dilution
of the extracellular recording solution.
Our standard drug-testing protocol was as follows. After recording a
stable control current in ACSF alone, we superfused the cells with ACSF
containing the drug for 2 to 3 min before recording. This was followed
by a washout with the control ACSF. We examined the reversal potential
of early NMDA currents by measuring the peak NMDA current amplitudes at
various holding membrane potentials that were set manually between
70
and +20 mV with voltage steps of 10 mV. We also used a ramp protocol to
determine the reversal potential of NMDA/glycine and
glycine-desensitized currents. The membrane potential was held at
100
mV for 8 s, whereas the cells were superfused with the agonists
and depolarized at a rate of 10 mV/s up to +40 mV.
Effects of zinc, bicuculline, and picrotoxin were tested by exposing
the neurons with these drugs for at least 1 min before applying either
GABA or glycine. Strychnine usually was coapplied with glycine although
in some cells strychnine was applied before glycine. We purchased
glycine, picrotoxin, taurine, ZnCl2,
BaCl2, bicuculline, strychnine, and GABA from
Sigma-Aldrich (St. Louis, MO). CGP 55845 was a gift from Novartis
Pharma (Basel, Switzerland).
We fitted the glycine dose-response curve with a Hill equation as
follows: I = Imax/[1 + (EC50/C)n],
where I, Imax,
C, EC50, and n are
glycine-activated current, maximal glycine-activated current, glycine
concentration, the concentration for 50% of maximum response, and the
Hill coefficient, respectively. We measured the voltage-dependent
glycine current desensitization using a linear regression formula in
DeltaGraph 4.5 (SPSS, Chicago, IL).
 |
Results |
Freshly Isolated NAcc Neurons.
Mechanical trituration after
enzymatic treatment of NAcc slices yielded cells of various sizes. Most
neurons had a small soma (Fig. 1, A-C)
and only a small population had a larger cell body (Fig. 1, D and E).
Neuronal shape also varied markedly; some neurons showed multipolar
processes (Fig. 1B), whereas others were bipolar and ovoid (Fig. 1, A
and C). Nevertheless, most of the small neurons recorded were likely to
be medium spiny cells, because they represent up to 90% of the total
number of cells in NAcc (Meredith and Totterdell, 1999
). The larger
neurons (Fig. 1D) are likely to be interneurons due to their size; few
of them are seen after an incubation of 30 min with papain (Bargas et
al., 1994
; Stefani et al., 1994
). Only neurons presenting a smooth and
shiny membrane were recorded, because these criteria usually correlate
with healthy cells.

View larger version (91K):
[in this window]
[in a new window]
|
Fig. 1.
Phase-contrast micrographs of neuron types acutely
isolated from the nucleus accumbens of 100- to 140-g rats. A to C,
typical neurons representing the majority of isolated cells in NAcc.
These had a relatively small soma and were either bipolar (A) or
multipolar (B and C). D and E, neurons with a larger cell body believed
to be a cholinergic interneurons. These neurons represent only a small
fraction of isolated NAcc cells. Scale bars (D and E), 10 µm.
|
|
Currents Evoked by Coapplication of NMDA and Glycine.
For 80%
of medium spiny neurons tested (class I; n = 54),
coapplication of 200 µM NMDA and 100 µM glycine (the NMDA receptor coagonist) evoked characteristic NMDA currents that were inward at
negative holding potentials and outward at positive ones (Fig. 2A), with the reversal potentials of both
peak and desensitizing currents near 0 mV (Fig. 1B). Interestingly, in
the remaining medium spiny neurons (class II; Fig. 2C), as well as in
all large interneurons (Fig. 2E, arrow), an equivalent coapplication of NMDA and glycine evoked a transient inward current that reversed around
0 mV, followed by a desensitizing current that became outward around
30 mV. To determine the nature of this desensitized outward current,
we examined its sensitivity to various ions. Because NMDA receptors can
be coupled to calcium-dependent chloride channels (Scott et al., 1995
),
we studied the NMDA effects in a Cl
-free
solution in class II neurons. In control solution, coapplication of
NMDA and glycine onto these neurons evoked an outward current around
20 mV. One minute after switching to a
Cl
-free solution the outward current was almost
entirely blocked, revealing the underlying NMDA current, whose
amplitude increased at negative holding potentials, possibly because
the shunt exerted by the chloride conductance was blocked (Fig.
3A). In addition, both peak and
desensitized currents reversed around 0 mV, and the NMDA current seemed
similar in shape to that of class I neurons (Fig. 2A). Because
Ca2+-dependent Cl
channels are blocked by Ba2+ (Scott et al.,
1995
), we substituted Ba2+ for
Ca2+. Surprisingly, Ba2+
did not prevent the outward current (Fig. 3A). Averaged over six cells,
the Cl
-free solution clearly shifted the
reversal potential of the outward current to around 0 mV, whereas
Ba2+ had no effect (Fig. 3B), suggesting the
absence of Ca2+-dependent
Cl
channels in class II NAcc neurons.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 2.
Heterogeneity of responses evoked by local
coapplication of 200 µM NMDA plus 100 µM glycine onto isolated NAcc
neurons in a Mg2+-free solution. A, typical currents evoked
by a 5-s NMDA application to a class I medium spiny neuron held between
70 and +20 mV. The current direction reversed at 0 mV. B,
current-voltage relationship of the peak (filled circles) and
desensitized (continuous line) currents of the cell shown in A. The
peak amplitude was measured at the potentials shown in A and the
desensitized current amplitude was measured using a ramp protocol (see
Materials and Methods). Both currents reversed near 0 mV. C, NMDA + glycine currents evoked from a typical class II medium
spiny neuron. Whereas the fast component of the current reversed at 0 mV (arrow), the desensitized one did not, but became outward at much
more negative potentials ( 30 mV). D, current-voltage relationship of
the cell shown in C illustrates the discrepancy between the early and
late reversal potentials. Note the strong outward rectification at
positive potentials. Inset E a similar class II-type NMDA + glycine
current in an NAcc interneuron.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of Cl -free,
Na+-free, and Ba2+-containing solutions on
NMDA/glycine currents of class II medium spiny neurons. A,
representative NMDA/glycine currents recorded between 60 and +30 mV
holding potentials. In control solution, the desensitized current
became outward at around 20 mV. The Cl -free solution
shifted the desensitized NMDA/glycine current equilibrium potential to
the right, whereas Ba2+-containing and Na+-free
solutions had little effect. The solid bar shown at 60 mV represents
the coapplication of NMDA and glycine for all traces. Note the dramatic
change of the current kinetics at +30 mV with the Cl -free
solution. B, current-voltage relationship of the effects of
Cl - and Na+-free and
Ba2+-containing solutions on the mean
(n = 6) current amplitudes induced by NMDA + glycine between 60 and +30 mV. Note the shift of the reversal
potential by a Cl -free solution (open circles).
|
|
We also ruled out the involvement of a mixed cationic
(Na+/K+) conductance,
because a Na+-free solution only slightly shifted
the reversal potential to the left (from
26 to
30 mV; Fig. 3B).
This small effect is probably due to a decrease of the inward NMDA
current amplitudes, clearly visible in Fig. 3, A and B, at negative
membrane potentials, that would weaken the NMDA inward currents
opposing the outward current and thus shift the apparent reversal
potential of the latter to the left. Although glycine currents were
generally very stable, as shown by the experiments on current
inactivation (see below), it is possible that exposure to
Ba2+, which sequentially preceded the
Na+-containing solution, may prevent glycine
currents from fully recovering.
Effects of Glycine Alone on Class II NAcc Neurons.
We asked
whether glycine alone could activate a similar outward current. At
70
mV, application of 100 µM glycine evoked an inward current that
decreased at more depolarized holding potentials and reversed around
50 mV (Fig. 4A). Using a ramp protocol
in 10 cells, the mean reversal potential of the glycine current was
50 ± 2 mV (
54 mV corrected for the liquid junction
potential), a value close to the theoretical value for
Cl
given by the Nernst equation (
55.4 mV)
with [Cl
]o of 145 mM
and estimated [Cl
]i of
10 mM. This current rectified outwardly at both depolarized and
hyperpolarized holding potentials (Fig. 4B). It is possible that part
of the rectification may be due to poor space clamping or to the
participation of unblocked voltage-gated channels. It is also possible
that fluoride, used in the recording pipette, passing through glycine
receptors may contribute to some extent to the rectification. However,
because the permeability of glycine receptors for this anion is the
lowest of the six tested by Fathima-Shad and Barry (1989)
, its
contribution is probably minimal.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Glycine alone evokes a current in NAcc
class II neurons. A, typical currents evoked by long (5-s) applications
of 100 µM glycine onto a class II neuron. Note the strong and rapid
desensitization of the current. The solid bar shown at 70 mV
represents the time of glycine application for all records. B,
current-voltage relationship of glycine currents evoked during a ramp
protocol. The potential was held initially at 100 mV, whereas the
cell was superfused with glycine and depolarized at a rate of 10 mV/s.
The average reversal potential was 50 ± 2 mV
(n = 10). Note the outward rectification. The
dashed line represents a theoretical linear current-voltage
relationship.
|
|
We assessed the affinity of glycine for the receptor by examining
currents evoked at 20-s intervals by 5-s epochs of glycine at
increasing concentrations. The relationship between the peak current
amplitude and glycine concentration (3 µM-1 mM) measured at 0 mV
holding potential is shown in Fig. 5A
(responses normalized to the peak current amplitude produced by 1 mM
glycine). The experimental data are well fitted by a theoretical curve
constructed from the Hill equation, with a Hill coefficient of 1.8 and
a EC50 of 11 × 10
5
(Fig. 5B), suggesting that at least two glycine molecules are needed to
activate each receptor. Although not systematically studied, we
observed that the desensitization of the current was profoundly altered
as the concentration of glycine increased (Fig. 5A). To characterize
these receptors further, we measured the desensitization (decay of the
current measured in continued presence of glycine) of glycine currents
at several holding potentials from
70 to +10 mV. At all potentials
(Fig. 6A;
Vh = 0 mV), glycine-mediated currents
desensitized very rapidly then returned close to baseline levels within
the 5-s application. The desensitization was best fitted with a double
exponential (Fig. 6A), as also shown for hypothalamic neurons and
Mauthner cells (Faber and Korn, 1987
; Akaike and Kaneda, 1989
). Between
80 and +10 mV, the mean fast and slow decay taus were 0.381 ± 0.23 and 1.705 ± 0.26 s, respectively (n = 8; Fig. 6B). Interestingly, the fast tau did not seem to be
voltage-dependent, unlike the slow desensitization that showed a clear
voltage dependence between
80 and +10 mV when fitted by linear
regression. A similar voltage dependence was reported by Akaike and
Kaneda (1989)
and Faber and Korn (1987)
.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Dose-response relationship for glycine-evoked
currents. A, representative responses evoked at 0 mV holding membrane
potential by 5-s glycine applications (solid column). The cell was
exposed to glycine concentrations from 3 µM to 1 mM. Traces obtained
with glycine concentrations of 10, 50, and 300 µM are omitted for
space reason. Note the change of the kinetics of the desensitization
associated with a change of glycine concentrations. B, mean amplitudes
averaged from five cells of peak currents in response to different
glycine applications. All cells were tested first at 1 mM and responses
to subsequent glycine concentrations normalized to this response
amplitude. Mean normalized responses were fit to the Hill equation
described under Materials and Methods. Apparent
EC50 = 110 µM.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Desensitization and inactivation of glycine-mediated
currents. A, 5-s application of 1 mM glycine evoked a strong
desensitization of the current recorded at 0 mV. The duration of the
superfusion is indicated by the solid bar below the current trace. The
desensitization was best fitted by a double exponential. The fast and
slow components are represented by a near vertical and a near
horizontal line, respectively. B, mean rapid (tau 1) and slow (tau 2)
desensitization rates of glycine currents measured at several holding
potentials between 80 and + 10 mV (n = 8).
Averaged tau values were fit by linear regression (see Materials
and Methods). C, current responses to a first conditioning
application of glycine followed at various intervals by test glycine
applications. Recordings of the conditioning responses seem darker
because six traces are superimposed. D, mean amplitude
(n = 5) of test responses relative to the peak
amplitude of conditioning glycine responses.
|
|
To further characterize glycine-mediated currents, we studied their
inactivation, a property associated with glycine receptors (Akaike and
Kaneda, 1989
), by measuring the responses of test glycine currents
after conditioning glycine applications at various intervals. Such
conditioning applications strongly inactivated test glycine currents at
2-s intervals. As the interval increased, the inactivation clearly
diminished (Fig. 6C): the mean average amplitude (n = 5) of the test glycine current at 2-s intervals was 48 ± 9% of
the conditioning current (Fig. 6D), increasing to 95 ± 4% at
14-s intervals.
Pharmacology of NAcc Glycine-Like Receptors.
We first examined
the effects of strychnine on the glycine current because this compound
is a highly selective and potent (IC50 = 5-10
nM) glycine receptor antagonist (Young and Snyder, 1973
, 1974
).
Surprisingly, glycine currents were strongly antagonized only with high
strychnine concentrations (10-100 µM) (Fig.
7A), whereas 1 µM strychnine, coapplied
with glycine decreased the mean glycine current amplitudes by only
18 ± 1.8% (n = 8; Fig. 7B), an equivalent
strychnine-insensitivity was found in three neurons where strychnine
was applied before glycine. The apparent strychnine
IC50 was 12 µM. We also examined the effects of
picrotoxin, an antagonist of both GABAA and
glycine receptors in some preparations (Rajendra et al., 1997
) on
glycine currents at 0 mV. A 1-min application of 50 µM picrotoxin
moderately decreased glycine current amplitudes (Fig.
8A). At a greater picrotoxin
concentration (200 µM) glycine current amplitudes were slightly
increased (data not shown). On average, 50 µM picrotoxin decreased
mean glycine current amplitudes by 15 ± 4%, whereas 200 µM
increased it by 22 ± 6% (Fig. 8C). We also examined the effects
of Zn2+, known to potentiate and to block glycine
currents at a low (1 µM) and high (10 µM) concentrations,
respectively (Bloomenthal et al., 1994
; Laube et al., 1995
); we found
that 1-min preincubation with 1 and 10 µM zinc only slightly
decreased glycine current amplitudes, by 8 ± 2 and 6 ± 2%,
respectively (Fig. 8C).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
Dose-response relationship for glycine-evoked
currents in the presence of increasing concentrations of strychnine. A,
representative responses evoked at 0 mV holding potential by
application of glycine (1 mM; solid column) and strychnine (0.01-100
µM; gray column). B, mean amplitudes averaged from eight cells of
peak glycine currents in the presence of different strychnine
concentrations. Strychnine IC50 = 12 µM.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
Neither picrotoxin nor zinc blocked the glycine
currents. A, 50 µM picrotoxin only slightly decreased the amplitude
of the current evoked by 100 µM glycine. B, in another NAcc cell, 10 µM zinc failed to block glycine currents. C, mean effects of
picrotoxin (50 and 200 µM; n = 5), and zinc (1 and 10 µM; n = 5) on glycine-evoked peak current
amplitudes. All these antagonists failed to markedly alter glycine
current amplitudes. All currents were recorded at 0 mV holding
potential. Neurons were preexposed to zinc.
|
|
What Is the Endogenous Ligand for NAcc Glycine-Like Receptors?
Because glycine-immunoreactive cells and fibers have not been
identified to date in forebrain structures such as NAcc (Rampon et al.,
1996
), we further examined the possibility that GABA could be the
endogenous transmitter for the glycine-like receptor. GABA applications
(500 µM) onto class II NAcc neurons evoked currents with strong
similarities to the glycine-evoked currents in that they displayed a
strong desensitization (Fig. 9A) and were
also strongly inactivated by a conditioning GABA application (data not
shown). Bicuculline (40 µM) moderately decreased the GABA currents
and altered the time to peak of the current, with a recovery on washout
(Fig. 9A). Averaged over four neurons, bicuculline decreased mean GABA
current amplitude by only 17 ± 6% (Fig. 9B). Because of the
surprising ineffectiveness of bicuculline we also tested picrotoxin
(200 µM), another potent GABAA receptor antagonist. As
with bicuculline, picrotoxin markedly altered the kinetics of the
currents, with recovery on washout (Fig. 9C). However, picrotoxin also
failed to fully antagonize the response (mean GABAA current
amplitudes decreased by 66 ± 12%; Fig. 9D). The persistence of a
sizable GABA current in the presence of a high concentration of
picrotoxin suggests that GABA may activate a conductance different from
that of GABAA receptors, although we cannot totally rule
out that the concentration of GABA used in our experiments may also
partially account for this effect due to competitive agonist/antagonist
interactions. This current did not involve GABAB receptors
because it was not altered by the presence in the recording solution of
a GABAB receptor antagonist (CGP 55845) or
Cs+, known to block potassium currents. Despite the fact
that the glycine current was strongly inactivated by a conditioning
glycine pulse, currents evoked by 500 µM GABA did not alter glycine
current amplitudes at any interapplication interval (Fig. 9E),
suggesting little interaction between GABAA and
glycine-like receptors in NAcc.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 9.
High concentrations of GABAA receptor
antagonists only partially reduced NAcc GABA currents. A,
representative GABA currents evoked by a 5-s GABA (0.5 mM) application
at VH = 0 mV in the continued presence
of the GABAB antagonist CGP 55845 (1 µM) before
(control), during, and after (wash) application of 40 µM bicuculine.
B, mean (n = 4) effects of bicuculine on GABA
current amplitudes measured at VH = 0 mV. C, effects of 200 µM picrotoxin on GABA currents at 0 mV. D, mean
GABA current amplitudes before, during, and after picrotoxin
application (n = 5). E, currents obtained by a
conditioning application of GABA followed at various intervals by test
glycine applications (bars). Recordings of the conditioning responses
appear darker because six GABA traces overlapped. Note that the GABA
conditioning currents did not inactivate glycine currents.
|
|
Because taurine, an amino acid with a high affinity for glycine
receptors, has been found in striatum and NAcc (see
Discussion), we tested its effects on NAcc neurons. class I
neurons devoid of glycine-like receptors did not respond to taurine
applications (n = 4). In contrast, class II NAcc
neurons and interneurons responded dose dependently to taurine as well
as to glycine applications (Fig. 10A);
taurine-evoked currents were maximal at 10 mM. To determine whether
taurine and glycine activate the same receptor, we first examined the
ability of taurine to inactivate glycine currents. Based on the results
of the previous experiments (Fig. 6, C and D), we elicited taurine
currents followed by glycine currents at critical intervals (1, 2, 4, and 20 s). As with the glycine/glycine inactivation experiments
(Fig. 6, C and D), 1 mM taurine strongly inactivated glycine currents
at the 1-s interval and the inactivation disappeared with a 20-s
interval (Fig. 10B; control glycine current not shown), suggesting that
both agonists interacted on the same receptor. The mean glycine current
amplitude was 53 ± 6 and 67 ± 4% of control for
interapplication intervals of 1 and 2 s, respectively (n = 6; Fig. 10C). To further test the ability of
glycine and taurine to interact, we showed that 10 mM taurine-mediated
currents were almost totally occluded by concurrent glycine
applications (1 mM) (Fig. 10D), the amplitude of the mean current
evoked by coapplication of glycine and taurine was 5 ± 4% of
control taurine current (n = 6).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 10.
Taurine inactivates glycine currents. A,
representative outward currents evoked by 5-s taurine (10 µM-1 mM)
and by glycine (100 µM) application in the same NAcc neuron held at 0 mV. B, current responses to a first conditioning application of 1 mM
taurine followed at various intervals by test glycine applications (1 mM). Recordings of the conditioning responses appear darker because
four traces are superimposed. Note the strong inactivation of glycine
currents at short interapplication intervals (1-4 s). C, mean
amplitude (n = 6) of test responses relative to the
peak amplitude of conditioning taurine responses. D, coapplication of
saturating concentrations of glycine and taurine occludes the taurine
current. The interval between each application is 20 s.
|
|
 |
Discussion |
In these experiments on acutely isolated NAcc neurons we found
that all NAcc interneurons and 20% of medium spiny cells expressed glycine-like receptors. Although their biophysical properties are
similar to those of other glycine receptors, their pharmacological properties set them apart. In addition, our data support the
possibility that taurine is an endogenous transmitter for NAcc
glycine-like receptors.
Identity of NAcc Glycine-Like Receptors.
These newly described
NAcc receptors exhibited a set of properties reminiscent of
strychnine-sensitive glycine receptors. Thus, NAcc glycine-evoked
currents rectified outwardly in both the hyperpolarizing and
depolarizing range, a phenomenon observed at voltages negative to
50
mV in cultured (Bormann et al., 1987
; Fatima-Shad and Barry, 1992
,
1993
) and acutely isolated hypothalamic (Akaike and Kaneda, 1989
)
neurons, as well as in recombinant glycine receptors in expression
systems (Gundersen et al., 1984
; Akagi et al., 1991
; Morales et al.,
1994
). The affinity of glycine for NAcc glycine-like receptors was 110 µM, a value similar to those obtained from glycine receptors in
hyothalamic, cerebellar, and ventral cochlear neurons (Akaike and
Kaneda, 1989
; Virginio and Cherubini, 1997
; Harty and Manis, 1998
).
NAcc glycine currents desensitized rapidly with a biphasic course, in
agreement with glycine receptors in other studies (Akaike and Kaneda,
1989
; Lewis et al., 1991
). However, in contrast to neurons in
hypothalamus (Akaike and Kaneda, 1989
), only the slow desensitization
was clearly voltage-dependent in NAcc neurons. NAcc glycine currents
also showed a strong inactivation, as reported for other glycine
receptors (Akaike and Kaneda, 1989
; Virginio and Cherubini, 1997
; Harty and Manis, 1998
).
Thus, NAcc glycine-like receptors share many properties
(desensitization and inactivation) of well characterized glycine
receptors. In addition, the lack of effect of picrotoxin, a property
thought to derive from low-conductance glycine receptors composed of
and
subunits (Legendre, 1997
; Yoon et al., 1998
), further
suggests the presence of a glycine receptor in NAcc. However, the
apparent presence of glycine receptors in NAcc is somewhat at odds with anatomical data. For example, glycine binding sites are extremely abundant in spinal cord and to a lesser extent in the midbrain, hypothalamus, cerebellum, and thalamus and are almost absent in forebrain structures such as cortex, NAcc, or dorsal striatum (Rajendra
et al., 1997
). An in situ hybridization study by Sato et al. (1991)
,
showing that forebrain regions lack
1 subunits, supported the
absence of glycine receptors in the forebrain. However, the same
authors (Sato et al., 1992
) showed that
2 subunits were expressed,
although at moderate levels, in the NAcc. Interestingly, a recent study
by Racca et al. (1998)
confirmed the presence of
2 subunits in the
forebrain (striatum) but also found the expression of
1 subunit
mRNA. It would be interesting to extend such immunohistochemical study
to the NAcc, to determine the kind of glycine receptor subunits expressed there and whether a similar expression in a subset of neurons
mirrors our electrophysiological data and the Racca et al. (1998)
findings in the dorsal striatum.
Although these findings do not directly demonstrate the presence of
functional glycine receptors, they may explain the ability of glycine
to evoke currents in some NAcc neurons. Indeed,
subunits, known to
carry glycine binding sites, are usually associated with the presence
of functional glycine receptors. The study by Racca et al. (1998)
also
may help explain the fact that glycine currents were partly restricted
in our study to interneurons, which represent only 5 to 10% of the
NAcc neuronal population. Although Racca et al. (1998)
reported only
weak-to-moderate levels of
1 mRNAs in striatum, they found a few
scattered, highly positive cells that could represent NAcc interneurons
and/or the fraction of medium spiny neurons that did show glycine
currents. The expression of
2 mRNA and more specifically the
presence of
2* subunit, if confirmed, may explain the surprisingly
weak strychnine effect we observed as these subunits are usually
considered to be less sensitive to strychnine (Vanderberg et al,
1992a
,b
). The method of coapplication of strychnine and glycine cannot
account for the relative ineffectiveness of strychnine compared with
published data (Young and Snyder, 1973
, 1974
), as preincubation of a
subset of cells with 1 µM strychnine (data not shown) also failed to block glycine currents as reported in other studies. We obtained a
similar result when testing the effects of 10 µM zinc (Fig. 8B).
Finally, although there are no data that would support the idea that
heteromeric glycine receptors composed of
1 and
2 subunits may be
combined to form functional NAcc glycine receptors, this hypothesis
cannot be ruled out given the extraordinary ability of subunits that do
not belong to the same class of receptors to form new entities (see below).
An alternative to the necessity for
1 and/or
2 proteins was
recently formulated by Betz et al. (1999)
, who proposed that
subunits, widely expressed in the forebrain (Fujita et al., 1991
;
Malosio et al., 1991
; Kirsch et al., 1993
; Racca et al., 1997
), along
with a protein yet to be identified, may form a novel complex that
retains only some of the properties of glycine receptors. Recent
studies indicate that receptors of different families can interact to
alter their individual properties. Thus, dopamine D2 and somatostatin
SST5 receptors, two structurally related G protein-coupled receptors,
can form a novel hetero-oligomer with pharmacological properties
different from those receptors alone (Rocheville et al., 2000
). A
similar heterodimerization was also reported for
- and
-opioid
receptors (Jordan and Devi, 1999
). With respect to ionotropic
receptors, the
subunit of GABAC receptors interacts with a novel splice variant of the glycine transporter GLYT-1
(Hanley et al., 2000
) that is also found in NAcc (Zafra et al., 1995
).
These findings challenge the dogma of strict boundaries between
receptors. Several studies (for review, see Rajendra et al., 1997
) have
established unequivocally that the primary sequence of glycine receptor
and
subunits share a considerable homology with subunits of
other multimeric receptors such as nicotinic (Noda et al., 1982
),
serotonin type 3 (Maricq et al., 1991
), and GABAA
receptors (Schofield et al., 1987
). Such similarities could support the
presence of receptors displaying distinct properties such as described herein.
Endogenous Agonist of NAcc Glycine-Like Receptors.
Regardless
of the exact identity of the subunits forming the NAcc glycine-like
receptors, the nature of their endogenous agonist remains to be
determined. Although glycine evoked the ionic conductance, this amino
acid may not be the endogenous ligand for the NAcc receptors because no
glycine-containing terminals have been detected in this region (Rampon
et al., 1996
). Because the primary structure of
GABAA and glycine receptors shares significant
sequence homologies, we examined the possibility that GABA could
activate the glycine-like receptors in NAcc. We found that picrotoxin,
a potent GABA receptor antagonist, did not totally block the
GABA-mediated currents, suggesting the involvement of either a GABA
receptor resistant to picrotoxin or a glycine receptor insensitive to
picrotoxin. The latter choice has some credibility, because the ability
of picrotoxin to block glycine receptors varies dramatically with the
subunit composition of the receptor. Thus,
homomeric glycine receptors are much more sensitive to picrotoxin block than heteromeric
plus
glycine receptors (Pribilla et al., 1992
). In addition, Fucile et al. (1999)
reported that GABA activates homomeric
1 glycine receptors from zebrafish. Similarly, in rat olfactory bulb
neurons both glycine and GABA can bind to either glycine or
GABAA receptors (Trombley et al., 1999
). However,
the fact that GABA failed to inactivate or occlude glycine currents
supports the idea that GABA does not bind to the glycine-like receptors.
If neither GABA nor glycine prove to be the endogenous ligand for this
novel NAcc glycine-like receptor, it is possible that another amino
acid with a high affinity for glycine receptors could serve that
function. Early studies on putative glycine receptor agonists
identified
-alanine and taurine as having a strong affinity for
glycine receptors (Curtis et al., 1968
; Young and Snyder, 1973
).
Taurine is a good candidate because it is the most abundant amino acid,
after glutamate, and is widely, although unevenly, distributed in the
brain (Palkovits et al., 1986
), including the NAcc (Madsen et al.,
1987
). Both taurine (Ottersen and Storm-Mathisen, 1986
; Madsen et al.,
1987
) and cysteine sulfinate decarboxylase, the enzyme responsible for
taurine biosynthesis (Legay et al., 1987a
,b
), have been found
predominantly in forebrain structures, including the striatum.
The presence of taurine in NAcc medium spiny neurons and its apparent
absence in terminals pose the question of its release. An interesting
parallel can be drawn between GABA and taurine in the NAcc. GABA, also
a nonvesicular transmitter, can be released into the extracellular
space from the soma by prolonged activation of excitatory amino acid
receptors (for review, see Attwell et al., 1993
), presumably by
an influx of Na+ through NMDA receptor channels
in neurons of striatum and NAcc (Schoffelmeer et al., 2000
). This would
explain why, in NAcc slices, we rarely observed
GABAA receptor antagonist-insensitive inhibitory postsynaptic potentials, because we evoked synaptic events only with
single stimulations; a train of stimuli would have been required for
nonvesicular release. It might also suggest that glycine receptors may
be silent under normal conditions. Furthermore, it is likely that these
glycine- and taurine-like receptors are the same entity because the
existence of a specific taurine receptor has yet to be demonstrated.
This idea is supported by the recent findings of Hussy et al. (2001)
who reported that taurine-mediated osmotic regulation in the
neurohypophysis is exerted through glycine receptors. To date, no
protein that could unequivocally account for this receptor has been
identified and characterized. In addition, our occlusion results
indicating that taurine acts on the same receptor as glycine further
strengthen the idea that taurine is an endogenous glycine receptor
agonist. It seems unlikely that taurine-mediated currents are the
result of GABAA receptor activation, because the
affinity of taurine for GABAA receptors is low.
In addition, if the response evoked by taurine reflected an effect on
GABAA receptors, the likelihood of
taurine-occluding glycine responses would be very small.
Furthermore, the presence of glycine
receptor subunits as well as
the newly reported
subunits, further strengthens the case for
existence of functional glycine receptors in the NAcc. Finally, these
NAcc glycine receptors present no apparent similarities to a newly
described excitatory glycine receptor (Chatterton et al., 2002
).
In conclusion, glycine elicits a current in some medium spiny neurons
and in all interneurons in the rat NAcc. Although many of the
biophysical properties of this current are similar to those of glycine
currents found in spinal cord and brain stem, its pharmacological characteristics set it apart. The activation of this receptor, as with
GABA receptors in most medium spiny neurons, should selectively inhibit
a subset of NAcc neurons.
We were indebted to Dr. J. Surmeier for considerable
assistance in setting up the acutely isolated neuron preparation. We also thank Drs. N Hussy, P. Schweitzer, and M. Tallent for helpful comments.
Accepted for publication May 13, 2002.
Received for publication January 23, 2002.
This research was supported by National Institutes of Health
Grants DA-03665 and AA-06420 (to G.R.S.) and DA-08301 (to S.J.H.).